A Phase III Randomized Trial of Intravenous Gammaglobulin Therapy for Patients With Neuroblastoma Associated Opsoclonus-Myoclonus-Ataxia Syndrome Treated With Chemotherapy and Prednisone.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Immune globulin (Primary) ; Cyclophosphamide; Prednisone
- Indications Neuroblastoma
- Focus Therapeutic Use
- 22 Oct 2020 Biomarkers information updated
- 11 Jun 2013 Planned end date changed from 1 Jan 2010 to 1 Dec 2014 as reported by ClinicalTrials.gov.
- 11 Jun 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.